6/15/2018China Adds Jinan and Changsha Airports as Drug Import Destination Port...

6/15/2018Recent Official and Executive Moves

6/15/2018Tsumura and PingAn Forms Chinese JV for Herbal Medicine

6/15/2018BMS Wins Chinese Approval of Opdivo as First PD-1/L1 Checkpoint in Chi...

6/15/2018Aptose Licenses China Rights of Crystal Genomics's AML Drug CG-806

6/15/2018China's Investors Pour Into Western Biotech Startups

6/15/2018China's Vaccine Tourists Drain Hong Kong's Supply of Cancer Drug

6/14/2018U.S. Supreme Court Rules against Chinese Companies in Vitamin Price-fi...

6/14/2018Sirtex Dumps Deal with Varian for Higher $1.4B Offer from CDH/China Gr...

6/13/2018Wuxi AppTech Leads Strategic Investment into AI Firm Insilico Medicine

6/13/2018CStone Initiates Two Pivotal Phase II Studies of Anti-PD-L1 mAb CS1001

6/13/2018BMJ: Protecting the Accuracy of Clinical Trial Data in China

6/13/2018China to Conduct Training Programs for Indian Pharma Cos

6/12/2018Chinese Government Launch Support Program for Biopharma CRO and CMO Se...

6/12/2018Suven Life Sciences Wins Patents in China and USA

6/11/2018WuXi Biologics to Build a $60M Biologics Facility in the U.S.

6/8/2018Recent Executive Moves

6/7/2018CNDA Suspends Import of Ambroxol Hydrochloride from India's Shilpa Med...

6/7/2018CNDA Solicits Comments on 2nd Draft of the GMP Appendices for Narcotic...

6/6/2018Hua Medicine Becomes Second Firm to Seek Hong Kong IPO under New Rules

6/6/2018CNDA Issues New Announcement (2018#30) for Clinical Data Self-Inspecti...

6/6/2018Shanghai Bans Hospital Pharmacy Contract Management by Pharma Companie...

6/6/2018Chinese Military Adds 513 Drugs to Its Rationalized Medicine Drug List

6/5/2018MNC Pharma Cos Face Uncertainties of Chinese Data Transfer Rules

6/5/2018CNDA Issues Notice to Strengthen Drug and Medical Device Regulation du...

6/5/2018Xynmic Pharma Completes Series B Financing As It Opens R&D Cen...

6/5/2018The Wistar Institute and Harbour BioMed Join Forces to Advance Novel A...

6/5/2018Denovo Licenses Stanford's DB102 for Pulmonary Arterial Hypertension

6/5/2018Chi-Med Cancer Trial Shows Clinically Meaningful Benefits

6/5/2018Sinobioway Biomedicine to Invest Nearly $500M in Massive Biologics Sit...

Page:138/334 Total number of articles:10001: [First][<<] [136] [137] [138] [139] [140] [>>] [End]